{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:34:10Z","timestamp":1789526050904,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.annonc.2026.02.008","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:25:14Z","timestamp":1771374314000},"page":"608-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours"],"prefix":"10.1016","volume":"37","author":[{"given":"K.S.","family":"Saini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Martins-Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Braendegaard Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Brahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bra\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Castelo-Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"de Azambuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dienstmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ekholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gallois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Golfinopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Halabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Le Rhun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Le Saux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.B.","family":"Leighl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lorenzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mountzios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.F.","family":"Oosting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Osterlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Perez-Gracia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pellat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Piperno-Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Punie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Remon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Ruhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.L.","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Stacchiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Suijkerbuijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Valachis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.W.M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pentheroudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Delaloge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Twelves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.annonc.2026.02.008_bib1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/2159-8290.CD-21-0212","article-title":"Independent drug action in combination therapy: implications for precision oncology","volume":"12","author":"Plana","year":"2022","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.annonc.2026.02.008_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00228-019-02818-7","article-title":"Individual factors increasing complexity of drug treatment-a narrative review","volume":"76","author":"Schmidt","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.annonc.2026.02.008_bib3","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1016\/S1470-2045(23)00186-9","article-title":"Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept","volume":"24","author":"Vitale","year":"2023","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.annonc.2026.02.008_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12885-019-5569-5","article-title":"Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis","volume":"19","author":"Vickers","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.annonc.2026.02.008_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13104-024-06789-6","article-title":"Concepts of lines of therapy in cancer treatment: findings from an expert interview-based study","volume":"17","author":"Falchetto","year":"2024","journal-title":"BMC Res Notes"},{"issue":"2","key":"10.1016\/j.annonc.2026.02.008_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41416-021-01319-8","article-title":"Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework","volume":"125","author":"Saini","year":"2021","journal-title":"Br J Cancer"},{"issue":"15","key":"10.1016\/j.annonc.2026.02.008_bib7","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2217\/fon-2020-1041","article-title":"Defining treatment regimens and lines of therapy using real-world data in oncology","volume":"17","author":"Hess","year":"2021","journal-title":"Future Oncol"},{"key":"10.1016\/j.annonc.2026.02.008_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102468","article-title":"Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer","volume":"111","author":"Schettini","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"10.1016\/j.annonc.2026.02.008_bib9","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/ijc.34853","article-title":"A prediction model for response to immune checkpoint inhibition in advanced melanoma","volume":"154","author":"van Duin","year":"2024","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.annonc.2026.02.008_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000526577","article-title":"Factors, including clinical trial eligibility, associated with induction of third-line treatment for advanced gastric cancer","volume":"101","author":"Ando","year":"2023","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.annonc.2026.02.008_bib11","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2024.35.e111","article-title":"Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer","volume":"35","author":"Olawaiye","year":"2024","journal-title":"J Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.annonc.2026.02.008_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11523-021-00845-y","article-title":"Phase II study of third-line panitumumab rechallenge in patients with metastatic wild-type KRAS colorectal cancer who obtained clinical benefit from first-line panitumumab-based chemotherapy: JACCRO CC-09","volume":"16","author":"Tsuji","year":"2021","journal-title":"Target Oncol"},{"key":"10.1016\/j.annonc.2026.02.008_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejca.2021.06.025","article-title":"Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas","volume":"154","author":"Kantidakis","year":"2021","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.annonc.2026.02.008_bib14","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/03007995.2022.2083326","article-title":"Non-small cell lung cancer with EGFR exon 20 insertion mutation: a systematic literature review and meta-analysis of patient outcomes","volume":"38","author":"Kwon","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.annonc.2026.02.008_bib16","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.2147\/CMAR.S328058","article-title":"The impasse on overall survival in oncology reimbursement decision-making: how can we resolve this?","volume":"13","author":"Lux","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.annonc.2026.02.008_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.17.00002","article-title":"Algorithm to identify systemic cancer therapy treatment using structured electronic data","volume":"1","author":"Carroll","year":"2017","journal-title":"JCO Clin Cancer Inform"},{"key":"10.1016\/j.annonc.2026.02.008_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920944052","article-title":"Comparing real-world evidence among patients with metastatic pancreatic ductal adenocarcinoma treated with liposomal irinotecan","volume":"12","author":"Koeller","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.annonc.2026.02.008_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102031","article-title":"Real world data in the era of immune checkpoint inhibitors (ICIs): increasing evidence and future applications in lung cancer","volume":"87","author":"Pasello","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"10.1016\/j.annonc.2026.02.008_bib21","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1182\/blood-2015-05-647636","article-title":"Guidelines for determination of the number of prior lines of therapy in multiple myeloma","volume":"126","author":"Rajkumar","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.annonc.2026.02.008_bib24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1287\/mnsc.9.3.458","article-title":"An experimental application of the DELPHI method to the use of experts","volume":"9","author":"Dalkey","year":"1963","journal-title":"Manag Sci"},{"issue":"6","key":"10.1016\/j.annonc.2026.02.008_bib25","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJMoa2502929","article-title":"First-line camizestrant for emerging ESR1-mutated advanced breast cancer","volume":"393","author":"Bidard","year":"2025","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.annonc.2026.02.008_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.euo.2020.07.001","article-title":"Patterns of cancer progression of metastatic hormone-sensitive prostate cancer in the ECOG3805 CHAARTED trial","volume":"3","author":"Bryce","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"10.1016\/j.annonc.2026.02.008_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.medj.2023.02.003","article-title":"The abscopal effect in patients with cancer receiving immunotherapy","volume":"4","author":"Nelson","year":"2023","journal-title":"Med"},{"issue":"13","key":"10.1016\/j.annonc.2026.02.008_bib28","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2217\/fon-2020-0994","article-title":"The abscopal effect of radiation therapy","volume":"17","author":"Craig","year":"2021","journal-title":"Future Oncol"},{"issue":"1","key":"10.1016\/j.annonc.2026.02.008_bib29","article-title":"Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spending","volume":"3","author":"Goldstein","year":"2024","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.annonc.2026.02.008_bib30","article-title":"Real-world evidence reported for clinical efficacy evaluation in European Public Assessment Reports of authorised targeted therapies for solid malignancies: a comprehensive review (2018-2022)","volume":"4","author":"Derksen","year":"2024","journal-title":"ESMO Real World Data Digit Oncol"},{"issue":"12","key":"10.1016\/j.annonc.2026.02.008_bib31","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.annonc.2023.10.001","article-title":"ESMO Guidance for Reporting Oncology real-World evidence (GROW)","volume":"34","author":"Castelo-Branco","year":"2023","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753426000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753426000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:15:14Z","timestamp":1784704514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753426000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0923753426000645"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2026.02.008","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2026.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}]}}